Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Day One Biopharmaceuticals Inc (DAWN)

Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Day One Biopharmaceuticals Inc 1800 Sierra Point Parkway Suite 200 Brisbane CA 94005 USA

www.dayonebio.com Employees: 178 P: 650-484-0899

Sector:

Medical

Description:

Day One Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It dedicated to developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Day One Biopharmaceuticals Inc. is based in SOUTH SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 2,198,181
Enterprise Value, $K 2,001,101
Shares Outstanding, K 103,298
Float, K 96,894
% Float 93.80%
Short Interest, K 10,285
Short Float 9.96%
Days to Cover 5.20
Short Volume Ratio 0.23
% of Insider Shareholders 6.20%
% of Institutional Shareholders 87.95%

Financials:

Annual Sales, $ 158,180 K
Annual Net Income, $ -107,320 K
Last Quarter Sales, $ 53,720 K
Last Quarter Net Income, $ -21,280 K
EBIT, $ -127,750 K
EBITDA, $ -123,960 K

Growth:

1-Year Return 145.38%
3-Year Return 17.60%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.19 on 11/04/25
Next Earnings Date 05/05/26
Earnings Per Share ttm -1.03
EPS Growth vs. Prev Qtr -5.26%
EPS Growth vs. Prev Year 71.01%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

DAWN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -23.43%
Return-on-Assets % -20.69%
Profit Margin % -67.85%
Debt/Equity 0.00
Price/Sales 13.93
Price/Cash Flow N/A
Price/Book 4.96
Book Value/Share 4.30
Interest Coverage -0.09
60-Month Beta -1.25
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar